{
  "basic_info": {
    "symbol": "MIRM",
    "name": "Mirum Pharmaceuticals Inc",
    "sector": "LIFE SCIENCES",
    "industry": "PHARMACEUTICAL PREPARATIONS",
    "country": "USA",
    "currency": "USD"
  },
  "market_data": {
    "market_cap": "2576795000",
    "shares_outstanding": "49534700",
    "52_week_high": "54.78",
    "52_week_low": "36.2",
    "50_day_ma": "49.48",
    "200_day_ma": "45.45"
  },
  "valuation_ratios": {
    "pe_ratio": "None",
    "peg_ratio": "None",
    "price_to_book": "11.05",
    "price_to_sales": "6.79",
    "ev_revenue": "6.9",
    "ev_ebitda": "-8.85"
  },
  "profitability_metrics": {
    "profit_margin": "-0.204",
    "operating_margin_ttm": "-0.136",
    "return_on_assets_ttm": "-0.0711",
    "return_on_equity_ttm": "-0.331",
    "gross_profit_ttm": "292420000"
  },
  "financial_strength": {
    "revenue_ttm": "379251000",
    "revenue_per_share_ttm": "7.9",
    "quarterly_revenue_growth": "0.612",
    "quarterly_earnings_growth": "0",
    "book_value": "4.717",
    "diluted_eps_ttm": "-1.61"
  },
  "dividend_info": {
    "dividend_per_share": "None",
    "dividend_yield": "None",
    "dividend_date": "None",
    "ex_dividend_date": "None"
  },
  "technical_indicators": {
    "beta": "0.971",
    "analyst_target_price": "68.7",
    "trailing_pe": "-",
    "forward_pe": "39.68"
  }
}